Table 2 Comparison between the three studied groups according to VAS
VAS | Duloxetine (n = 10) | Gabapentin (n = 10) | Botox (n = 10) | F | p |
|---|---|---|---|---|---|
VAS 0 | |||||
Mean ± SD | 8 ± 1.1 | 7.5 ± 1.1 | 8.1 ± 0.7 | 1.098 | 0.348 |
Median (Min.–Max.) | 8 (6–9) | 7.5 (6–9) | 8 (7–9) | ||
VAS 1 week | |||||
Mean ± SD | 7.5 ± 1.4 | 6.6 ± 1.6 | 7.3 ± 0.8 | 1.231 | 0.308 |
Median (Min.–Max.) | 7.5 (6–9) | 6.5 (4–9) | 7.5 (6–8) | ||
VAS 4 weeks | |||||
Mean ± SD | 6.3 ± 1.2 | 5.7 ± 1.3 | 5.5 ± 0.8 | 1.431 | 0.257 |
Median (Min.–Max.) | 6.5 (4–8) | 6 (4–8) | 5.5 (4–7) | ||
VAS 12 weeks | |||||
Mean ± SD | 5.8 ± 0.9 | 5.5 ± 1.1 | 6.2 ± 1 | 1.202 | 0.316 |
Median (Min.–Max.) | 5.5 (5–7) | 5 (4–8) | 6 (5–8) | ||